Figure 1From: Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol Flow chart describing the selection, randomization and follow-up process of the Clinical Evaluation of the Dose of Erythropoietins (C.E. DOSE) trial.Back to article page